2022HY052

N/A

Report date: 2024/01/16 14:57:11

Base Information

Drug Name2022HY052
Drug Alias Name2022HY0522022HY-052
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBronchial Spasm
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Bio-Sincerity Pharma-Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Bio-Sincerity Pharma-Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsBronchial Spasm
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A